Vital Signs - Cardiovascular Imaging and Informatics - 2014 European Society of Cardiology Congress Highlights
Recently, there has been much debate about a looming deterioration in the environment offered by the
United States for high-tech companies to conduct their research and development (R&D) and innovation efforts.
When the Medical Device Excise Tax was enacted a couple of years ago, it was perceived by some as a major hit
against the United States’ appeal as an innovation hub for MedTech companies.
Many predicted the decision to fund part of the Affordable Care Act by imposing a 2.3% lower margin on
medical device makers would signify the beginning of an inescapable move offshore of United States technology
and market innovations. While the long-term effect of higher tax rates remains to be seen, in medical imaging
today, the innovation slowdown in the United States seems to owe much more to another factor—the delay
in regulatory approvals.
About this report
As with every cardiology tradeshow today, the show floor of the 2014 European Society of Cardiology (ESC) Congress in Barcelona (Aug. 30-Sept. 3) reserved quite a significant presence for medical imaging. This comes as no surprise, since imaging and informatics continues to reaffirm their role as an important driving force for advancing several areas of the cardiovascular care continuum— from non-invasive diagnostic imaging to image guidance during interventional procedures, to driving the entire department’s workflow.
Electronic Access - Site License Fulfilled by Publisher
Electronic Access - Global site License Fulfilled By Publisher